Showing results (171-180 of 819) with videos related to

Sort By:
Pageof 82
Bioengineering & Translational Medicine|November 29, 2023
Genetically engineered nano-melittin vesicles for multimodal synergetic cancer therapyJianzhong Zhang, Xue Liu, Yutian Xia, et al.
Bioengineering & Translational Medicine|March 4, 2024
A drug-selectable acoustic reporter gene system for human cell ultrasound imagingAlessandro R Howells, Phoebe J Welch, John Kim, et al.
Bioengineering & Translational Medicine|March 4, 2024
Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote scar-less wound healing in preclinical modelsWei Wang, Liang Chen, Yuxin Zhang, et al.
Bioengineering & Translational Medicine|March 4, 2024
An AI-assisted integrated, scalable, single-cell phenomic-transcriptomic platform to elucidate intratumor heterogeneity against immune responseChristopher P Tostado, Lucas Xian Da Ong, Joel Jia Wei Heng, et al.
Bioengineering & Translational Medicine|May 31, 2024
The emerging role of heart-on-a-chip systems in delineating mechanisms of SARS-CoV-2-induced cardiac dysfunctionRick Xing Ze Lu, Yimu Zhao, Milica Radisic
Bioengineering & Translational Medicine|May 31, 2024
Non-contact immunological signaling for highly-efficient regulation of the transcriptional map of human monocytesDina Hashoul, Walaa Saliba, Yoav Y Broza, et al.
Bioengineering & Translational Medicine|May 31, 2024
Sensor-integrated brain-on-a-chip platforms: Improving the predictive validity in neurodegenerative researchSarah Spitz, Silvia Schobesberger, Konstanze Brandauer, et al.
Bioengineering & Translational Medicine|May 31, 2024
Next-generation agents for fluorescence-guided glioblastoma surgeryCristina Chirizzi, Serena Pellegatta, Alessandro Gori, et al.
Bioengineering & Translational Medicine|May 31, 2024
Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapyElizabeth E Sweeney, Palak Sekhri, Nethaji Muniraj, et al.
Bioengineering & Translational Medicine|November 15, 2024
AAVS1-targeted, stable expression of ChR2 in human brain organoids for consistent optogenetic controlSoojung Hong, Juhee Lee, Yunhee Kim, et al.
Pageof 82